Contraception

Latest News



From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.

Long-acting reversible contraceptives (LARCs) are not only highly effective, they are appropriate under a variety of conditions. Here, the authors present 3 scenarios in which patients would benefit from LARC methods.

Topical or intracervical 2% lidocaine gel applied before intrauterine device (IUD) insertion does not decrease pain scores, but there are other ways to lessen discomfort.

An intrauterine device (IUD) is an effective tool in the treatment of early-stage endometrial cancer in certain patients, according to the results of a small study presented at the International Gynecological Cancer Society’s 14th biennial meeting.

This video demonstrates a case in which an intrauterine device (IUD) IUD was trapped--not in the uterine cavity and not outside the uterine wall, but within the muscle of the uterus. It was extracted under laparoscopic guidance.

In the largest study of its kind, researchers found increased risk for myocardial infarction and thrombotic stroke in women using combined estrogen-progestin contraceptives. However, news headlines tend to overstate the risk, and patients may have new concerns about the safety of their hormonal contraceptive.

Typically used for long-term contraception, the intrauterine device (IUD) is also an effective emergency contraceptive if implanted after unprotected sex. Two IUDs, which are T-shaped pieces of plastic, are available in the United States.